The NeutroFlow consortium is composed of four partners from four different EU and affiliated countries bringing together the necessary expertise and resources for achieving the project goals.
OncoHost
A biotechnology start-up developing novel precision oncology blood-based tests.
Developed and launched PROphetNSCLCTM - a plasma proteomics-based laboratory-developed test (LDT) for supporting clinical decisions in NSCLC.
Contribution to NeutroFlow project: overall project management; technological expertise for product development; business know-how for future commercialization.
European Institute of Oncology
One of the world's most prestigious hospitals and the fastest growing comprehensive cancer centre in Europe.
The IEO clinical flow cytometry facility is among the largest in Italy active in diagnosis and follow-up of >1500 cancer patients per year.
Contribution to NeutroFlow project: providing blood samples; on-site flow cytometry analysis; leading flow cytometry-related activities and analytical validation of the prototype.
Heidelberg University Hospital
The largest medical centre in Germany, ranked 13th among the “World’s Best Hospitals”, 2023.
The Thoraxklinik subsidiary, is one of the largest specialized hospitals for lung diseases in Europe.
Contribution to NeutroFlow project: providing blood samples; on-site flow cytometry analysis; leading communication and dissemination activities.
Virgen Macarena University Hospital - Servicio Andaluz de Salud
A public healthcare entity with a broad network of hospitals in Spain.
>200 active clinical trials and a research unit dedicated to Research & Innovation projects in the field of Medical Informatics.
Contribution to NeutroFlow project: providing blood samples; on-site flow cytometry analysis; leading the clinical study.
